Leeford Healthcare Ltd
Levosulpiride (75mg) + Esomeprazole (40mg)
Esomefol SL 75mg/40mg Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux) by relieving symptoms such as heartburn, stomach pain, or irritation.
Capsule SR
Esomefol SL 75mg/40mg Capsule SR is a prescription medicine used in the treatment of gastroesophageal reflux disease (acid reflux). It works by relieving the symptoms such as heartburn, stomach pain, or irritation. It also neutralizes the acid production in the stomach to prevent discomfort.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Esomefol SL 75mg/40mg Capsule SR is to be taken empty stomach.
Esomefol SL 75mg/40mg Capsule SR is a combination of two medicines: Levosulpiride and Esomeprazole.
Do not consume alcohol while taking Esomefol SL 75mg/40mg Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Esomefol SL 75mg/40mg Capsule SR for longer than prescribed.
Keep this medicine in its original container or pack, tightly closed. Store it according to the directions on the package or label provided. Do not misuse the medication by consuming it. Make sure it is out of reach of children, pets and other people.
Take Esomefol SL 75mg/40mg Capsule SR exactly as directed by your doctor. It is best to take one capsule daily on an empty stomach.
The use of Esomefol SL 75mg/40mg Capsule SR should be avoided in patients with known allergies to any of the components or excipients of this medicine.
Yes, the use of Esomefol SL 75mg/40mg Capsule SR may lead to dizziness (feeling faint, weak, unsteady, or lightheaded) in some patients. If you feel dizzy or lightheaded, it is best to rest and resume once you feel better.
Several studies in adults indicate that treatment with Esomefol SL 75mg/40mg Capsule SR may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist, or spine. The risk of fracture was higher in patients who received high doses. High dose means multiple daily doses and long-term therapy (for a year or longer).